Multimedia update -- nasdaq-listed prenetics and david beckham officially launch im8 health

Beckham is a strategic investor in prenetics and co-founding partner for im8 im8 launch marks a bold entry into the $187 billion global consumer health market launch follows recently announced prenetics' acquisition of europa, one of the largest sports nutrition distributors in the u.s. im8 is now available at www.im8health.com , shipping to 31 countries (david beckham pictured with the beckham stack) charlotte, n.c., nov. 18, 2024 (globe newswire) -- prenetics, (nasdaq: pre) a leading health sciences company, in partnership with david beckham, today announced the official launch of im8.
NDAQ Ratings Summary
NDAQ Quant Ranking